Narayana Hrudayalaya Reports Robust Q2 FY26 Results with 29.6% Jump in Net Profit
Narayana Hrudayalaya's Q2 FY26 results show significant growth. Revenue increased by 20.3% to ₹16,438.00 million, EBITDA grew 28.3% to ₹4,265.00 million, and net profit rose 29.6% to ₹2,583.00 million. India revenue grew 8.8%, while Cayman revenue surged 78.1%. The company plans to expand bed capacity from 7,600+ to over 7,685 by FY30, with projects in Bangalore, Raipur, and Kolkata. Digital transformation initiatives are underway to enhance patient experience and operational efficiency.

*this image is generated using AI for illustrative purposes only.
Narayana Hrudayalaya , a leading healthcare provider, has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth across key metrics.
Financial Highlights
The company's consolidated performance for Q2 FY26 showed impressive year-over-year improvements:
| Metric | Q2 FY26 | Q2 FY25 | YoY Change |
|---|---|---|---|
| Revenue | ₹16,438.00 | ₹13,667.00 | 20.3% |
| EBITDA | ₹4,265.00 | ₹3,323.00 | 28.3% |
| EBITDA Margin | 25.9% | 24.3% | 160 bps |
| Net Profit | ₹2,583.00 | ₹1,993.00 | 29.6% |
| Net Profit Margin | 15.7% | 14.6% | 110 bps |
Operational Performance
The company's strong financial results were underpinned by robust operational performance:
- India Revenue grew by 8.8% year-over-year to ₹12,347.00 million
- Cayman Revenue saw a substantial increase of 78.1% to ₹4,316.00 million
Segment-wise Performance
Narayana Hrudayalaya's business mix for Q2 FY26 in India hospital operations was as follows:
- Owned Hospitals: 73%
- Operated Hospitals: 25%
- Heart Centres: 1%
The company's specialty profile showed a diverse mix, with Cardiac Sciences leading at 33%, followed by Oncology at 15%, and Medicine and GI sciences at 14%.
Key Financial Ratios
As of September 30, 2025, Narayana Hrudayalaya reported strong financial ratios:
- Debt Equity Ratio: 0.58
- Interest Service Coverage Ratio: 7.99
- Current Ratio: 2.20
- Operating Margin: 24.49%
- Net Profit Margin: 15.71%
Management Commentary
Dr. Emmanuel Rupert, Managing Director & Group CEO, stated, "Our Q2 FY26 results reflect the continued strength of our healthcare model and the dedication of our team. The significant growth in revenue and profitability demonstrates the resilience of our operations and the increasing demand for quality healthcare services."
Future Outlook
Narayana Hrudayalaya continues to focus on expanding its presence in key regions. The company plans to increase its bed capacity from the current 7,600+ to over 7,685 by FY30, with expansion projects in Bangalore, Raipur, and Kolkata.
The company is also making strides in digital transformation, with initiatives aimed at enhancing patient safety and experience, as well as improving operational efficiencies.
Narayana Hrudayalaya's strong Q2 FY26 performance, coupled with its expansion plans and digital initiatives, positions the company well for continued growth in the healthcare sector.
Note: All financial figures are in Indian Rupees (₹) unless otherwise stated.
Historical Stock Returns for Narayana Hrudayalaya
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.33% | -3.14% | +0.56% | -1.45% | +37.37% | +386.07% |













































